157 related articles for article (PubMed ID: 8378535)
21. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
Little MP
Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of atomic bomb survivors.
Sakata R; Grant EJ; Ozasa K
Maturitas; 2012 Jun; 72(2):99-103. PubMed ID: 22440534
[TBL] [Abstract][Full Text] [Related]
23. Dose response and temporal patterns of radiation-associated solid cancer risks.
Preston DL; Pierce DA; Shimizu Y; Ron E; Mabuchi K
Health Phys; 2003 Jul; 85(1):43-6. PubMed ID: 12852470
[TBL] [Abstract][Full Text] [Related]
24. Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk.
Hayashi Y; Lagarde F; Tsuda N; Funamoto S; Preston DL; Koyama K; Mabuchi K; Ron E; Kodama K; Tokuoka S
Cancer; 2010 Apr; 116(7):1646-55. PubMed ID: 20120034
[TBL] [Abstract][Full Text] [Related]
25. Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958-2005.
Kaiser JC; Misumi M; Furukawa K
Int J Radiat Biol; 2021; 97(1):19-30. PubMed ID: 32573332
[TBL] [Abstract][Full Text] [Related]
26. Thyroid diseases in cohort studies of A-bomb survivors.
Shimaoka K; Shibata Y; Akiba S
Thyroidology; 1994 Aug; 6(2):37-41. PubMed ID: 7536448
[TBL] [Abstract][Full Text] [Related]
27. The influence of follow-up on DS02 low-dose ranges with a significant excess relative risk of all solid cancer in the Japanese A-bomb survivors.
Walsh L; Schneider U
Radiat Environ Biophys; 2016 Nov; 55(4):509-515. PubMed ID: 27586509
[TBL] [Abstract][Full Text] [Related]
28. Thyroid diseases among atomic bomb survivors in Nagasaki.
Nagataki S; Shibata Y; Inoue S; Yokoyama N; Izumi M; Shimaoka K
JAMA; 1994 Aug; 272(5):364-70. PubMed ID: 8028167
[TBL] [Abstract][Full Text] [Related]
29. Salivary gland tumors among atomic bomb survivors, 1950-1987.
Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
[TBL] [Abstract][Full Text] [Related]
30. Thyroid cancer: epidemiological study of thyroid cancer in A-bomb survivors from extended life span study cohort in Hiroshima.
Ezaki H; Takeichi N; Yoshimoto Y
J Radiat Res; 1991 Mar; 32 Suppl():193-200. PubMed ID: 1762106
[TBL] [Abstract][Full Text] [Related]
31. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.
Imaizumi M; Usa T; Tominaga T; Neriishi K; Akahoshi M; Nakashima E; Ashizawa K; Hida A; Soda M; Fujiwara S; Yamada M; Ejima E; Yokoyama N; Okubo M; Sugino K; Suzuki G; Maeda R; Nagataki S; Eguchi K
JAMA; 2006 Mar; 295(9):1011-22. PubMed ID: 16507802
[TBL] [Abstract][Full Text] [Related]
32. Effect of radiation dose on the height of atomic bomb survivors: a longitudinal study.
Nakashima E; Fujiwara S; Funamoto S
Radiat Res; 2002 Sep; 158(3):346-51. PubMed ID: 12175312
[TBL] [Abstract][Full Text] [Related]
33. Radiation-related risks of non-cancer outcomes in the atomic bomb survivors.
Ozasa K; Takahashi I; Grant EJ
Ann ICRP; 2016 Jun; 45(1 Suppl):253-61. PubMed ID: 26956675
[TBL] [Abstract][Full Text] [Related]
34. Exposure to ionizing radiation and brain cancer incidence: The Life Span Study cohort.
Smoll NR; Brady Z; Scurrah K; Mathews JD
Cancer Epidemiol; 2016 Jun; 42():60-5. PubMed ID: 27038588
[TBL] [Abstract][Full Text] [Related]
35. A parallel analysis of cancer mortality among atomic bomb survivors and patients with ankylosing spondylitis given X-ray therapy.
Darby SC; Nakashima E; Kato H
J Natl Cancer Inst; 1985 Jul; 75(1):1-21. PubMed ID: 3859683
[TBL] [Abstract][Full Text] [Related]
36. Exposure to ionizing radiation in adulthood and thyroid cancer incidence.
Richardson DB
Epidemiology; 2009 Mar; 20(2):181-7. PubMed ID: 19177023
[TBL] [Abstract][Full Text] [Related]
37. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
[TBL] [Abstract][Full Text] [Related]
38. Ionizing radiation exposure and the development of soft-tissue sarcomas in atomic-bomb survivors.
Samartzis D; Nishi N; Cologne J; Funamoto S; Hayashi M; Kodama K; Miles EF; Suyama A; Soda M; Kasagi F
J Bone Joint Surg Am; 2013 Feb; 95(3):222-9. PubMed ID: 23389785
[TBL] [Abstract][Full Text] [Related]
39. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases.
Ozasa K; Shimizu Y; Suyama A; Kasagi F; Soda M; Grant EJ; Sakata R; Sugiyama H; Kodama K
Radiat Res; 2012 Mar; 177(3):229-43. PubMed ID: 22171960
[TBL] [Abstract][Full Text] [Related]
40. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
Little MP; Hall P; Charles MW
Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
